Although FMNL1 was tightly correlated with immune infiltration in HCC, and even in pan-cancer, it was a novel biomarker for immune cells, but might not be a critical regulator in tumor cells to mediate tumor immunity due to the distinctive expression pattern of FMNL1. This evidence concerns the gene FMNL1 and hepatocellular carcinoma.